Inovio Pharmaceuticals, Inc.
NASDAQ: INO
$1.88
-$0.09 (-4.6%)
Closing price May 20, 2022
Wednesday afternoon's top analyst upgrades and downgrades included Inovio Pharmaceuticals, McDonald’s, Orchard Therapeutics, VBI Vaccines and Wingstop.
4 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings, Inovio, Netflix, Snowflake and more.
1 year ago
Friday's top analyst upgrades and downgrades included AngloGold Ashanti, Fisker, News Corp, QuantumScape, Williams-Sonoma, YETI and Zillow.
1 year ago
Last Updated: 1 year ago
Inovio Pharmaceuticals shares soared on Monday after the company provided an update for its coronavirus vaccine candidate.
1 year ago
Things aren’t looking up for Inovio Pharmaceuticals, after the FDA notified the company that it was placing a partial hold on its COVID-19 vaccine study.
1 year ago
While COVID-19 pandemic is not its only target, that has been the main driver of the interest in Inovio Pharmaceuticals so far in 2020.
1 year ago
Friday's top analyst upgrades and downgrades included Amazon.com, Broadcom, Boeing, DraftKings, eBay, Electronic Arts, Hilton Worldwide, iRobot, NetApp, Peloton Interactive and Tesla.
1 year ago
Last Updated: 1 year ago
Inovio Pharmaceuticals has announced that it received $71 million in funding from the U.S. Department of Defense to support the production of its delivery device for the COVID-19 vaccine.
1 year ago
Thursday's top analyst upgrades and downgrades included Aerojet Rocketdyne, Avis Budget, Carnival, Chipotle Mexican Grill, Expedia, Home Depot, Lowe's, MGM Resorts, Stratasys, Square and Walmart.
2 years ago
Last Updated: 2 years ago
Wednesday's top analyst upgrades and downgrades included Alphabet, Advanced Micro Devices, Corning, FireEye, Inovia Pharmaceuticals, Lululemon Athletica, Nike, Roku, Starbucks, Tyson Foods and...
2 years ago
Last Updated: 2 years ago
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
2 years ago
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
2 years ago
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
2 years ago
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
2 years ago
Markets looked like they would be crushed yet again on Monday. 24/7 Wall St. has tracked some stocks that either are defensive in general or were defying Monday’s big drop.
2 years ago